The BSG has published a joint statement covering advice on COVID-19 booster vaccination for people with liver disease
A joint statement—from the British Society of Gastroenterology (BSG), British Association for the Study of the Liver, and British Liver Trust—has been published that provides advice on COVID-19 booster vaccination for people with liver disease.
People with chronic liver disease are considered to be at high risk from COVID-19. Although vaccines may be less effective in people with chronic liver disease and in those post-liver transplant, they still provide significant protection.
It is recommended in the statement that people with chronic liver disease, especially those receiving immunosuppressive treatment, agree to either a third dose or a booster dose of a COVID-19 vaccine when it is offered to them.
The statement also contains information on the difference between the third primary dose and booster dose of the vaccine, and provides some background to the existing BSG and Joint Committee on Vaccination and Immunisation advice.
Lead image: Anna Kosolapova/stock.adobe.com
Image 1: Anna Kosolapova/stock.adobe.com